Who is sponsoring NCT04703413?

NCT04703413 is sponsored by Wellspect HealthCare.

What drugs are being tested in NCT04703413?

Interventions in NCT04703413: LoFric® OrigoTM and LoFric® SenseTM.

What condition does NCT04703413 study?

NCT04703413 studies Bladder Voiding Dysfunction.

Is NCT04703413 still recruiting?

NCT04703413 is currently terminated. Last updated 28 April 2023.

Last reviewed 2023-04-28 · How we verify

NCT04703413

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

User Satisfaction When Catheterizing With Hydrophilic Urinary Catheters From a More Sustainable Manufacturing Process.

Terminated NA Last updated 28 April 2023

What this trial tests

NA trial testing LoFric® OrigoTM and LoFric® SenseTM in Bladder Voiding Dysfunction in 50 participants. Terminated before completion.

Timeline

17 December 2020

Primary endpoint
15 April 2023

15 April 2023

Quick facts

Lead sponsor	Wellspect HealthCare
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	50
Start date	17 December 2020
Primary completion	15 April 2023
Estimated completion	15 April 2023
Sites	3 locations across Germany

Drugs / interventions tested

LoFric® OrigoTM and LoFric® SenseTM

Conditions studied

Bladder Voiding Dysfunction — all drugs for Bladder Voiding Dysfunction →

Sponsor

Wellspect HealthCare

Who can join

18 and older, any sex, with Bladder Voiding Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An open, prospective, single arm, multicenter clinical investigation. All subjects will use the investigational device for 30 days each.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Wellspect HealthCare trials

Trials by the same sponsor.

NCT06385249 — An Evaluation of Navina Mini, a New Trans-anal Irrigation (TAI) Device in Children and Adolescents · NA · completed
NCT06377280 — En Evaluation of Navina Mini, a New Low-volume Transanal Irrigation Device. · NA · completed
NCT05644912 — Exploratory Investigation on a Novel Catheter · NA · completed
NCT04304599 — Evaluation of a New Female Urinary Intermittent Catheter · NA · completed
NCT05359198 — Patient Reported Outcome Study on Long Term LoFric Users · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04703413 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wellspect HealthCare
Last refreshed: 28 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04703413.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing